Ottobock, DE000BCK2223

Ottobock stock gains WIM S distribution role in North America

Published on 11/18/2026 at 11:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ottobock stock gains a North American distribution role for WIRobotics' WIM S wearable robot. Sales will begin in the United States.

Ottobock expands wearable robotics reach

  • WIRobotics announced a distribution agreement covering the United States and Canada, with sales starting in the United States.
  • WIM S will be sold through online platforms and introduced at selected orthotic and prosthetic clinics.
  • The companies will assess broader trial locations and a later extension of sales to Canada.
Ottobock, DE000BCK2223, Illustration mit AI erstellt.

On Wednesday, November 18, WIRobotics announced a distribution and sales agreement with Ottobock for its WIM S wearable mobility robot in North America. The announcement, published by PR Newswire, said WIRobotics USA had signed the agreement with Otto Bock HealthCare LP on October 15. Ottobock will serve as the distribution partner in the United States and Canada.

Sales will start in the United States. Customers will be able to buy WIM S through Ottobock's online platform and WIRobotics USA's online store. Selected orthotic and prosthetic clinics will also offer consumers the opportunity to try the wearable robot.

United States launch comes first

The initial rollout is focused on the United States rather than a simultaneous launch across both markets. The companies said they will use customer feedback to consider additional trial locations and a later expansion of sales to Canada.

The partnership combines WIRobotics' wearable robotics technology with Ottobock's distribution, clinical-care and service networks in the United States and Canada. The companies also plan to work together on market development, brand building, product training and after-sales service. WIRobotics USA will support local training and service operations.

WIRobotics said WIM has exceeded 4,000 cumulative units sold and has expanded beyond South Korea into Europe, China and Japan. The partners also see potential to extend their collaboration to WIM Medi, which WIRobotics is developing for medical use. The release did not provide financial terms for the agreement.

Stock quote and investor context

Ottobock stock traded at 38.70 euros on Lang & Schwarz at 11:37 CET on Wednesday, November 18. The North American agreement gives the company a new channel for wearable mobility technology, while the commercial rollout and later Canadian expansion remain the next operational milestones.

Ottobock stock at a glance

  • Company: Ottobock SE & Co. KGaA
  • ISIN: DE000BCK2223
  • Trading venue: Lang & Schwarz
  • Quote: 38.70 euros at 11:37 CET on November 18, 2026
  • Agreement: WIM S distribution in the United States and Canada

In the broader market, investors can follow the German benchmark through DAX market reports.

More news and analyses on Ottobock stock

Disclaimer...
en | DE000BCK2223 | OTTOBOCK | boerse | 70530522 | bgmi